CXO Intelligence Series · Sub-series
AI in FDA and EMA regulated environments, where a decision can reach a patient.
This track covers AI where the regulator is already in the room: computer system validation and continuous assurance, ALCOA+ data integrity, GAMP 5, 21 CFR Part 11 and EU Annex 11, and what it takes for a model that learns to be provable rather than merely accurate.
First edition in preparation · ISSN: applied for · Bengaluru, India
The track
This track is announced but not yet open. The first edition is in preparation. Until it publishes, the closest work sits in the Governance Series, which already covers AI in FDA and EMA regulated environments, and in the Enterprise AI Series.
This is a sub-series, not a separate publication. The Life Sciences Series is one named track inside the CXO Intelligence Series, an independent, weekly AI thought leadership journal for the C-suite on building the AI-native enterprise. It is vendor-neutral and published from Bengaluru. Journal particulars, the full archive and the road ahead are on the series page.
Journal particulars and full archive Browse the full article index
Subscribe
The series publishes here first, in HTML and PDF, and on LinkedIn the same day.